Common use of Protocol Title Clause in Contracts

Protocol Title. “A 2-year extension study to evaluate long-term effectiveness of Mavenclad® in participants who have completed Trial MS700568_0022 (MAGNIFY MS)” Protocol Date: 20 August 2020 Sponsor: Merck Healthcare KGaA Country where Site is Conducting Study Czech Republic Location where the study will be conducted: Neurology clinic, which is a division/part of the Institution Key Enrollment Date: 100 Calendar Days after Site Initiation Visit (being the date by which Site must enrol at least one (1) subject as more specifically set out in section 1.9 “Key Enrollment Date” below)

Protocol Title. “A 2-year extension study to evaluate long-term effectiveness of Mavenclad® in participants who have completed Trial MS700568_0022 (MAGNIFY MS)” Protocol Date: 20 August 2020 Sponsor: Merck Healthcare KGaA Country where Site is Conducting Study Czech Republic Location where the study will be conducted: Neurology clinic, which is a division/part of the Institution Key Enrollment Date: 100 Calendar Days after Site Initiation Visit (being the date by which Site must enrol at least one (1) subject as more specifically set out in section 1.9 “Key Enrollment Date” below)